Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A

Author's Avatar
Jan 11, 2022

- For 30 years, Terumo's radial access product portfolio has changed the way clinicians perform coronary care procedures -

PR Newswire